The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):
Visit the "Peripheral Vascular Diseases Group" website here

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here


View stages (what is this?): all titles Titles protocol Protocols review Reviews

Angioplasty (versus non surgical management) for intermittent claudication
Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)
Anticoagulant thromboprophylaxis for medical diagnostic and speciality subgroups (title stage)
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism.
Antiplatelet agents for intermittent claudication (protocol stage)
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
Atherectomy for peripheral arterial disease (protocol stage)
Autologous versus prosthetic arteriovenous fistulae for vascular access (protocol stage)
Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction
Beta blockers for peripheral arterial disease (protocol stage)
Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)
Buflomedil for intermittent claudication
Updated
Bypass surgery for chronic lower limb ischaemia
Calcium channel blockers for primary Raynaud's Phenomenon (protocol stage)
Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery
Chelation therapy for atherosclerotic cardiovascular disease
Cilostazol for peripheral arterial disease
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)
Complementary and alternative medicine for Raynaud's phenomenon. (title stage)
Compression stockings for preventing deep vein thrombosis in airline passengers
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome
Cryoplasty for peripheral vascular disease
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement (title stage)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Dressings and topical agents for arterial leg ulcers
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Elastic compression stockings for prevention of deep vein thrombosis
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Endovascular assisted in situ vein bypass versus conventional in situ vein bypass for peripheral arterial bypass surgery (title stage)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
Endovascular repair versus open repair for inflammatory aneurysms (title stage)
Endovascular stents for intermittent claudication
Endovascular treatment for ruptured abdominal aortic aneurysm
Endovascular versus conventional treatment for type B aortic dissection (protocol stage)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices. (protocol stage)
Exercise for intermittent claudication
Fibrinolytic agents for peripheral arterial occlusion (protocol stage)
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
Garlic for peripheral arterial occlusive disease
Gene therapy for peripheral arterial disease (protocol stage)
General versus loco-regional anaesthesia for endovascular aneurysm repair (title stage)
Generic warfarin versus branded warfarin for patients at risk of thromboembolic events (title stage)
Ginkgo biloba for intermittent claudication (protocol stage)
withdrawn
Graft materials for open abdominal aortic aneurysm repair (protocol stage)
Graft type for femoro-popliteal bypass surgery
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and MI) (protocol stage)
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Home versus in-patient treatment for deep vein thrombosis
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
Horse chestnut seed extract for chronic venous insufficiency
Infusion techniques for peripheral arterial thrombolysis
Injection sclerotherapy for varicose veins
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy
Intravascular brachytherapy for peripheral vascular disease
Intravenous fluids for abdominal aortic surgery
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
New
Intravenous immunoglobulin for Wegener's granulomatosis (protocol stage)
Intravenous naftidrofuryl for critical limb ischaemia
New
Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis (protocol stage)
L-carnitine for intermittent claudication (protocol stage)
Lipid-lowering for peripheral arterial disease of the lower limb
Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization (protocol stage)
withdrawn
Manual compression versus vascular sealing devices for arterial puncture sites (title stage)
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
New
Naftidrofuryl for intermittent claudication
Non-pharmaceutical measures for prevention of post-thrombotic syndrome
Omega-3 fatty acids for intermittent claudication
Once versus twice daily LMWH for the initial treatment of venous thromboembolism
New
Oral vasodilators for primary Raynaud's phenomenon
Padma 28 for intermittent claudication (title stage)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pentoxifylline for intermittent claudication (protocol stage)
Phlebotonics for venous insufficiency
Physical treatments for non-complicated chronic venous insufficiency (protocol stage)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Prevention of infection in arterial reconstruction
Prevention of venous insufficiency in a standing workers population (protocol stage)
Primary stenting versus angioplasty for patients with iliac artery occlusive disease (title stage)
Prostanoids for critical limb ischemia (protocol stage)
Prostanoids for intermittent claudication
Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation
Radiological versus surgical placement for tunnelled central venous lines (title stage)
Recombinant tissue plasminogen activator plus heparin versus heparin alone for stable pulmonary embolism (title stage)
withdrawn
Risk assessment versus no risk assessment for preventing deep vein thrombosis and pulmonary embolism in surgical patients (protocol stage)
Rutosides for prevention of post thrombotic syndrome (protocol stage)
Rutosides for treatment of post-thrombotic syndrome (protocol stage)
Salicylate for the treatment of Kawasaki disease in children
Screening for abdominal aortic aneurysm
Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Steroid sex hormones for lower limb atherosclerosis
Stripping of the long saphenous veins for treatment of varicose veins (title stage)
Subcutaneous unfractionated heparin for the treatment of venous thromboembolism (protocol stage)
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
Surgery for deep venous incompetence
Surgery for small asymptomatic abdominal aortic aneurysms
Surgery for varicose veins: use of tourniquet
Surgery versus non-surgical treatment for femoral pseudoaneurysms
Surgery versus sclerotherapy for the treatment of varicose veins
Surgery versus thrombolysis for initial management of acute limb ischaemia
Sympathectomy for peripheral arterial disease (protocol stage)
The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (title stage)
Thoracic stent graft versus surgery for thoracic aneurysm (protocol stage)
Thoracic stent graft versus surgery for traumatic thoracic transection (protocol stage)
Thrombolysis for acute deep vein thrombosis
Thrombolytic therapy for pulmonary embolism
Thrombolytics for massive pulmonary embolism in normotensive patients with right heart strain (title stage)
New
Thrombophilia testing for prevention of recurrent venous thromboembolism (protocol stage)
Treatment for superficial thrombophlebitis of the leg
Treatment of hypertension in peripheral arterial disease
Type of incision for below knee amputation
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in high risk patients (title stage)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in high-risk patients (title stage)
Vena caval filters for the prevention of pulmonary embolism
Vitamin E for intermittent claudication
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
Warfarin initiation nomograms for venous thromboembolism (title stage)